ライフサイエンスコーパス: not significantly different

1 Discontinuation rates were also not significantly different in both groups (odds ratio, 1.13;

2 nd of fine co-ordination of the dominant hand (p=0.038) and not significantly different on other cognitive tests (p>0.05)

3 PTB rates were low and not significantly different with exposure to the new ration.I

4 ce (VM) for male mating success and competitive fitness are not significantly different from zero, whereas VM for hermaph

5 ignificantly restricted compared to ovulating patients, but not significantly different between high- and low-risk pregna

6 rent mean values, with only a limited number of comparisons not significantly different between the instruments.

7 the collective frequency of unbinding events in WT-RBCs is not significantly different from that of SS-RBCs.

8 of total tumor before treatment (503.1 mm(3) +/- 204.6) was not significantly different from those after treatment (P = .

9 eiver-operator characteristic curve (AUC) of UMT (0.84) was not significantly different from that of BinaxNOW Pf (0.86) o

10 treatment, gametocyte sex ratio became male-biased and was not significantly different between the DP and DP-PQ groups.

11 The FAZ area was not significantly different from normal (all P >/= .24).

12 height to crypt depth ratio in distal duodenal biopsies was not significantly different between those who received the va

13 entage of absorption of alpha-carotene from raw carrots was not significantly different from beta-carotene when adjusting

14 PrEP efficacy was not significantly different between women with detected G vag

15 Change in personality (ie, slope), however, was not significantly different between the nonimpaired and the A

16 isual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and sham

17 cerebral palsy or other major neurological impairments was not significantly different between groups.

18 Following corneal inoculation of mice, the mutant was not significantly different from wild-type virus in terms of

19 Postprogression OS was not significantly different between the chemotherapy plus bev

20 The 30-day composite end point was not significantly different between suction-based extraction

21 etween betaPPA at baseline and visual field progression was not significantly different between AD and ED eyes (beta = 0.

22 The success rate was not significantly different at 6 months (81% vs 61%, P = .20)

23 e genetic correlation between the P wave and PR segment was not significantly different from 0 (rG=-0.03 [0.16]).

24 nfarction (MI), or nonperiprocedural ipsilateral stroke was not significantly different between therapies (OR: 1.22; 95%

25 Thirty-day survival was not significantly different in patients who received a high F

26 The rate of peripapillary choroidal thinning was not significantly different between healthy and glaucoma eyes

27 The incidence of IRIS, and drug toxicity was not significantly different between trial arms.

28 rate of in-hospital death or withdrawal from treatment was not significantly different between urban and rural hospitals

29 ntage decrease in prevalence after age 12 was 1%, which was not significantly different from zero (95% confidence interva

30 WTP was not significantly different between villages that had partici

31 1 kg/m(2)] vs 29.8 kg/m(2) [range, 22.9-44.0 kg/m(2)]) were not significantly different.

32 n 3 months of the inciting event, 0.08+/-0.15 (20/25), were not significantly different than those undergoing surgical in

33 Effect sizes for each symptom on adherence were not significantly different between the treatment groups ( P

34 in spine and femoral neck bone mineral contents (BMCs) were not significantly different in the treatment groups.

35 Changes in composite endpoint components were not significantly different between ASV and control.

36 e changes in angle parameters, ACA, and iris curvature were not significantly different between the 2 groups.

37 ortality and overall serious adverse events at 90 days were not significantly different across groups.

38 Adverse events were not significantly different between treatment arms.

39 Regeneration rates of ABOi grafts were not significantly different from those of ABOc grafts.

40 8 years]), the combined rates of functional impairment were not significantly different between the 457 children assigned

41 yrosine kinase/Ras/Raf pathway including EGFR and KRAS were not significantly different between populations in lung adeno

42 The LT, VL, AL, and LAF were not significantly different among the three groups.

43 spa types found in meat were not significantly different regardless of the store or county

44 The basophil tests' diagnostic performances were not significantly different.

45 full professorship among female and male radiologists were not significantly different (absolute adjusted difference for

46 SUVs for any RR were not significantly different over time.

47 erse events, quality of life, and patient satisfaction were not significantly different between the two arms.

48 itures related to appropriate and inappropriate shocks were not significantly different.

49 s showed that the scores from the 28-8 and E1L3N tests were not significantly different but that the 22c3 test showed a s

50 s, rates of thrombosis, hemorrhage, and transformation were not significantly different; however, some disease-related sy